Polomar Health Services Inc. has announced a significant amendment to its financial agreement with Reprise Management, Inc. As part of a Second Amendment to an existing Promissory Note, the company has reduced its principal debt from $897,549.74 to $597,549.74 using proceeds from the sale of newly designated Series A Convertible Preferred Stock. The remaining balance will now be subject to a simplified annual interest rate of 12%, with the maturity date extended to July 31, 2027. Additionally, Polomar has entered into a Securities Purchase Agreement, issuing 60 shares of the preferred stock to Reprise for $300,000, which will be allocated toward paying down the principal of the Reprise Note. This strategic move aims to streamline the company's debt obligations and improve its financial structure.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。